DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Balar AV, Galsky MD, Rosenberg JE. et al; IMvigor210 Study Group.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Lancet 2017;
389 (10064): 67-76
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.